News Releases

Wednesday, February 19, 2014

University Hospitals to study if insulin spray can slow early Alzheimer’s disease: ‘SNIFF’ Trial

CLEVELAND – In a new clinical trial, University Hospitals (UH) Case Medical Center researchers will be testing whether an insulin spray in the nose can help improve the symptoms of mild Alzheimer’s disease (AD) and a precursor to AD called amnestic mild cognitive impairment (aMCI).  
 
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF), will examine a new therapeutic approach using intranasal insulin that has shown promise in short-term clinical trials. Researchers are recruiting patients with early stage AD or mild cognitive impairment and UH Case Medical Center will be one of 30 national sites.

University Hospitals named Official Health Care Partner of the Cleveland Browns
Friday, January 31, 2014

University Hospitals named Official Health Care Partner of the Cleveland Browns

CLEVELAND – Today, the Cleveland Browns made official the partnership that makes University Hospitals (UH) in Cleveland the official health care partner of the Cleveland Browns for the next 10 years. 
 
As the Official Health Care Partner of the Browns, University Hospitals Case Medical Center, the health system’s nationally recognized academic medical center, will provide a complete team of physician specialists covering every aspect of the team’s health care needs. 

Wednesday, January 29, 2014

Study finds mammography beneficial for younger women

CLEVELAND – Researchers from University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine have published new findings in the February issue of American Journal of Roentgenology that mammography remains beneficial for women in their 40s. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy.
 
In recent years, there have been contradictory guidelines related to the benefit of annual mammograms for women in their 40s. The United States Preventive Services Task Force’s guidelines from 2009 recommend against annual screening mammography for women in that age group while the American Cancer Society, American College of Radiology and other professional societies recommend annual exams beginning at age 40.

Tuesday, January 28, 2014

UH Rainbow Babies & Children’s diabetes physician-researcher charts future directions for landmark diabetes study in Journal Diabetes Care

CLEVELAND – The two most highly cited diabetes research trials – Diabetes Control and Complications Trial (DCCT) and its follow-up study Epidemiology of Diabetes Interventions and Complications (EDIC) – are marking their 30th anniversary. DCCT, which ran from 1982 to 1993, enrolled more than 1,400 adolescents and young adults with type 1 diabetes to evaluate if intensive control of diabetes could lower the risk of complications better than conventional control. EDIC launched in 1994 and continues to follow many patients from the original study.
 
This month, the journal Diabetes Care, published by the American Association of Diabetes, features a series of articles commemorating the anniversary of the groundbreaking studies. University Hospitals Rainbow Babies & Children’s Hospital (UH Rainbow)/Case Western Reserve University School of Medicine together have constituted a lead center in DCCT/EDIC, the longest-running study funded by the National Institutes of Health.

Thursday, January 16, 2014

UH Case Medical Center among the first to perform major heart surgery under ‘twilight’

CLEVELAND – University Hospitals Case Medical Center cardiologists Marco Costa, MD, and Dan Simon, MD, are among the first in the country to perform transaortic valve replacements (TAVR) while the patient is in a “twilight” sedation, awake and communicating with them during the procedure.

What was previously major, open-heart surgery is now being done percutaneously in the cath lab with excellent results that include less recovery time and improved infection rates. On average, patients receiving the new technique are returning home within 24 hours, dramatically reducing hospital stay duration and overall associated medical costs usually incurred during a lengthy admission. 


You must be logged in to view this item.



Login

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.